AC-102

N/A

Report date: 2024/01/05 15:51:15
NME

Base Information

Drug NameAC-102
Drug Alias NameAC-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis inhibitorsBrain-derived neurotrophic factor expression stimulantsInflammation mediators modulators
TargetsBrain-derived neurotrophic factorInflammation mediators
Therapy Area/IndicationsTinnitusHearing Loss, SuddenHearing Loss, Sensorineural
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUkrainePoland +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAudioCure Pharma GmbH
China Registration ClassN/A

Develop Information

Active CompaniesAudioCure Pharma GmbH
Inactive CompaniesN/A
Active IndicationsTinnitusHearing Loss, SuddenHearing Loss, Sensorineural
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A